Logo: Four dots and StockDot set in typeface Coolvetica
An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for ABBVIE Inc
Ticker ABBV
FIGI BBG0025Y4RY4
CUSIP 00287Y109
Sector Healthcare
Equity Type Common Stock
No. Companies Holding this Equity 3203 / 45.7%
Percentage held by institutional investors 78.1%

About

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74. The company's primary product is Humira (adalimumab) ($14 billion in 2023 revenues, 27 percent of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohn's disease, plaque psoriasis, and ulcerative colitis. Wikipedia